According to the FDA-approved prescribing information, gastrointestinal adverse reactions (nausea, vomiting, diarrhea) occur in up to 43% of patients taking Mounjaro and 37% of patients taking Zepbound, with higher rates during dose escalation phases
The Wegovy pill has met the MHRA's standards for safety, quality and effectiveness and is only supplied after a prescriber has reviewed your medical history
349 Single large-scale mtDNA deletions exhibit phenotypic heterogeneity and contribute to a spectrum of diseases, including Pearson syndrome, Kearns-Sayre syndrome, and PEO
Over the past few years, incretins have been clinically validated as targets and are now the emerging standard of care therapies in obesity, but could also be effective in other metabolic indications, as well as in cardiovascular and chronic kidney disease
Most people reach their target dose around week 1317
Understanding potential interactions between levothyroxine and weight loss injections is crucial for optimal therapeutic outcomes